Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome
Camilia Metadea Aji Savitri1,2, Takashi Matsumoto1,3, Kartika Afrida Fauzia2,4
1Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Gastric cancer risk may involve more than Helicobacter pylori, as pathogenic factors influence microbial diversity. Other stomach bacteria may impact disease outcomes or offer protection, warranting further research.
Area of Science:
- Microbiology
- Gastroenterology
- Genomics
Background:
- Global gastric cancer incidence is not fully explained by Helicobacter pylori infection rates or pathogenicity.
- Investigated pathogenic factors of H. pylori and their interactions with the gastric microbiome in Indonesia, a population with low gastric cancer but high gastritis rates.
Purpose of the Study:
- To investigate the role of H. pylori pathogenic factors and their interaction with the gastric microbiome.
- To explore the influence of co-habiting bacteria on gastric disease outcomes.
Main Methods:
- Analyzed 66 H. pylori-positive gastric biopsies using 16S rRNA sequencing.
- Examined microbiome diversity (α and β) and abundance, alongside H. pylori pathogenic factors.
- Utilized correlation analysis (SECOM) and predicted functional inference (PICRUSt2).
Main Results:
- Virulent H. pylori genotypes correlated with greater microbial diversity, suggesting co-colonization.
- Specific taxa like Veillonella and Klebsiella showed notable abundance across pathogenic subtypes.
- Microbial diversity varied with H. pylori polymorphisms (CagA, sabA, homA/B, iceA) and decreased with worsening atrophy.
- Helicobacter showed a positive correlation with Veillonella; Streptococcus correlated with several gastric taxa.
- Predicted functional analysis indicated pathway depletion with disease progression.
Conclusions:
- Pathogenic factors of H. pylori significantly impact gastric microbial diversity.
- Co-habiting bacteria in the stomach may influence disease outcomes.
- Further research is needed to understand the role of non-Helicobacter species in gastric pathologies.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...


